{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T18:53:42Z","timestamp":1661367222474},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T00:00:00Z","timestamp":1238457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s12149-009-0230-z","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T18:05:17Z","timestamp":1238436317000},"page":"235-243","source":"Crossref","is-referenced-by-count":7,"title":["Role of carbon-11 choline PET\/CT in the management of uterine carcinoma: initial experience"],"prefix":"10.1007","volume":"23","author":[{"given":"Keitaro","family":"Sofue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Terauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuro","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,31]]},"reference":[{"key":"230_CR1","first-page":"842","volume":"38","author":"T Hara","year":"1997","unstructured":"Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med. 1997;38:842\u20137.","journal-title":"J Nucl Med"},{"key":"230_CR2","first-page":"990","volume":"39","author":"T Hara","year":"1998","unstructured":"Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39:990\u20135.","journal-title":"J Nucl Med"},{"key":"230_CR3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s002590100655","volume":"28","author":"PL Jager","year":"2001","unstructured":"Jager PL, Que TH, Vaalburg W, Prium J, Elsinga P, Plukker JT. Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Eur J Nucl Med. 2001;28:1845\u20139.","journal-title":"Eur J Nucl Med"},{"key":"230_CR4","first-page":"167","volume":"43","author":"RM Pieterman","year":"2002","unstructured":"Pieterman RM, Que TH, Elsinga PH, Pruim J, van Putten JW, Willemsen AT, et al. (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. J Nucl Med. 2002;43:167\u201372.","journal-title":"J Nucl Med"},{"key":"230_CR5","first-page":"331","volume":"44","author":"IJ Jong de","year":"2003","unstructured":"de Jong IJ, Prium J, Elsinga PH, Vaalburg W, Mensink HJ. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med. 2003;44:331\u20135.","journal-title":"J Nucl Med"},{"key":"230_CR6","first-page":"938","volume":"47","author":"M Picchio","year":"2006","unstructured":"Picchio M, Treiber U, Beer AJ, Metz S, Bossner P, van Randenborgh H, et al. Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med. 2006;47:938\u201344.","journal-title":"J Nucl Med"},{"key":"230_CR7","first-page":"1064","volume":"31","author":"M Tian","year":"2004","unstructured":"Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging. 2004;31:1064\u201372.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"230_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00259-006-0190-7","volume":"34","author":"B Scher","year":"2007","unstructured":"Scher B, Seitz M, Albinger W, Tiling R, Scherr M, Becker HC, et al. Value of (11)C-choline PET and PET\/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging. 2007;34:45\u201353.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"230_CR9","first-page":"1051","volume":"44","author":"T Torizuka","year":"2003","unstructured":"Torizuka T, Kanno T, Futatsubashi M, Okada H, Yoshikawa E, Nakamura F, et al. Imaging of gynecologic tumors: comparison of 11C-choline PET with 18F-FDG PET. J Nucl Med. 2003;44:1051\u20136.","journal-title":"J Nucl Med"},{"key":"230_CR10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"230_CR11","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","volume":"35","author":"H Young","year":"1999","unstructured":"Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer. 1999;35:1773\u201382.","journal-title":"Eur J Cancer"},{"key":"230_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/gyno.2001.6504","volume":"84","author":"Y Nakamoto","year":"2002","unstructured":"Nakamoto Y, Eisbruch A, Achtyes ED, Sugawara Y, Reynolds KR, Johnston CM, et al. Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. Gynecol Oncol. 2002;84:289\u201395.","journal-title":"Gynecol Oncol"},{"key":"230_CR13","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1200\/JCO.2004.09.035","volume":"22","author":"PW Grigsby","year":"2004","unstructured":"Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol. 2004;22:2167\u201371.","journal-title":"J Clin Oncol"},{"key":"230_CR14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ygyno.2004.08.037","volume":"95","author":"Y Yoshida","year":"2004","unstructured":"Yoshida Y, Kurokawa T, Kawahara K, Yagihara A, Tsuchida T, Okazawa H, et al. Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-Fluorodeoxyglucose positron emission tomography: preliminary results in three patients. Gynecol Oncol. 2004;95:597\u2013602.","journal-title":"Gynecol Oncol"},{"key":"230_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ygyno.2005.10.005","volume":"101","author":"F Xue","year":"2006","unstructured":"Xue F, Lin LL, Dehdashti F, Miller TR, Siegel BA, Grigsby PW. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol. 2006;101:147\u201351.","journal-title":"Gynecol Oncol"},{"key":"230_CR16","first-page":"1200","volume":"44","author":"R Bar-Shalom","year":"2003","unstructured":"Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET\/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200\u20139.","journal-title":"J Nucl Med"},{"key":"230_CR17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0969-8043(98)00097-9","volume":"50","author":"T Hara","year":"1999","unstructured":"Hara T, Yuasa M. Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot. 1999;50:531\u20133.","journal-title":"Appl Radiat Isot"},{"key":"230_CR18","volume-title":"UICC TNM classification of malignant tumours","author":"LH Sobin","year":"2002","unstructured":"Sobin LH, Wittekind C. UICC TNM classification of malignant tumours. 6th ed. New York: Wiley; 2002.","edition":"6"},{"key":"230_CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet JL, Bender H, Jones H III, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70:209\u201362.","journal-title":"Int J Gynaecol Obstet"},{"key":"230_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1148\/radiology.171.1.2928532","volume":"171","author":"K Togashi","year":"1989","unstructured":"Togashi K, Nishimura K, Sagoh T, Minami S, Noma S, Fujisawa I, et al. Carcinoma of the cervix: staging with MR imaging. Radiology. 1989;171:245\u201351.","journal-title":"Radiology"},{"key":"230_CR21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1148\/radiol.2312021184","volume":"231","author":"R Manfredi","year":"2004","unstructured":"Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology. 2004;231:372\u20138.","journal-title":"Radiology"},{"key":"230_CR22","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1200\/JCO.2001.19.17.3745","volume":"19","author":"PW Grigsby","year":"2001","unstructured":"Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 2001;19:3745\u20139.","journal-title":"J Clin Oncol"},{"key":"230_CR23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1148\/radiol.2381041799","volume":"238","author":"S Sironi","year":"2006","unstructured":"Sironi S, Buda A, Picchio M, Perego P, Moreni R, Pelleqrino A, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET\/CT. Radiology. 2006;238:272\u20139.","journal-title":"Radiology"},{"key":"230_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11307-005-0023-2","volume":"8","author":"M Heinisch","year":"2006","unstructured":"Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, et al. Positron emission tomography\/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5\u00a0ng\/ml? Mol Imaging Biol. 2006;8:43\u20138.","journal-title":"Mol Imaging Biol"},{"key":"230_CR25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2214\/AJR.05.0437","volume":"187","author":"F Gutman","year":"2006","unstructured":"Gutman F, Aflalo-Hazan V, Kerrou K, Montravers F, Grahek D, Talbot JN. 18F-choline PET\/CT for initial staging of advanced prostate cancer. AJR Am J Roentogenol. 2006;187:618\u201321.","journal-title":"AJR Am J Roentogenol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-009-0230-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-009-0230-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-009-0230-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:41:13Z","timestamp":1559450473000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-009-0230-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,31]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1007\/s12149-009-0230-z","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,31]]}}}